Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pages: 110 Published: May 31, 2022 Report Code: GDGMDHC22086TDB

Aryl hydrocarbon receptor (AHR) plays an important role in the development and maturation of many tissues. Moreover, it regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1.

The AHR pipeline market research report provides comprehensive information on the AHR targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research, and development history as well as the latest news and press releases. Additionally, the report provides an overview of key players involved in Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics development with respective active and dormant or discontinued projects.

Key Therapy Areas in the AHR Pipeline Products Market

The key therapy areas in the AHR pipeline products market are oncology, immunology, gastrointestinal, dermatology, central nervous system, infectious disease, metabolic disorders, ophthalmology, and respiratory. Oncology has the highest number of pipeline products in the AHR pipeline products market.

AHR Pipeline Products Market Analysis by Therapy Areas

AHR Pipeline Products Market Analysis by Therapy Areas

For more therapy area insights, download a free report sample

Key Mechanisms of Action in the AHR Pipeline Products Market

The key mechanisms of action in the AHR pipeline products market are Aryl Hydrocarbon Receptor Agonist and Aryl Hydrocarbon Receptor Antagonist.

AHR Pipeline Products Market Analysis by Mechanisms of Action

AHR Pipeline Products Market Analysis by Mechanisms of Action

For more mechanisms of action insights, download a free report sample

Key Routes of Administration in the AHR Pipeline Products Market

The key routes of administration in the AHR pipeline products market are oral, intravenous, inhalational, intraarticular, and topical.

AHR Pipeline Products Market Analysis by Routes of Administration

AHR Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

Key Molecule Types in the AHR Pipeline Products Market

The key molecule types in the AHR pipeline products market are small molecule, biologic, synthetic peptide, cell therapy, and monoclonal antibody.

AHR Pipeline Products Market Analysis by Molecule Types

AHR Pipeline Products Market Analysis by Molecule Types

For more molecule type insights, download a free report sample

Major Companies in the AHR Pipeline Products Market

Some of the major companies in the AHR pipeline products market are Actavalon Inc, Active Biotech AB, Ampio Pharmaceuticals Inc, AnTolRx Inc, Aqilion AB, Artus Therapeutics Inc, Aslan Pharmaceuticals Ltd, Azora Therapeutics Australia Pty Ltd, Bayer AG, and Dermavant Sciences Inc.

AHR Pipeline Products Market Analysis by Companies

AHR Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

AHR Pipeline Products Market Report Overview

Key Therapy Areas Oncology, Immunology, Gastrointestinal, Dermatology, Central Nervous System, Infectious Disease, Metabolic Disorders, Ophthalmology, and Respiratory
Key Mechanisms of Action Aryl Hydrocarbon Receptor Agonist and Aryl Hydrocarbon Receptor Antagonist
Key Routes of Administration Oral, Intravenous, Inhalational, Intraarticular, and Topical
Key Molecule Type Small Molecule, Biologic, Synthetic Peptide, Cell Therapy, and Monoclonal Antibody
Major Companies Actavalon Inc, Active Biotech AB, Ampio Pharmaceuticals Inc, AnTolRx Inc, Aqilion AB, Artus Therapeutics Inc, Aslan Pharmaceuticals Ltd, Azora Therapeutics Australia Pty Ltd, Bayer AG, and Dermavant Sciences Inc

Scope

  • The report provides a snapshot of the global therapeutic landscape for Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR)
  • The report reviews Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
  • The report reviews key players involved in Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics and enlists all their major and minor projects
  • The report assesses Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews the latest news and deals related to Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics

Reasons to Buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
  • Identify and understand the targeted therapy areas and indications for Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR)
  • Identify the use of drugs for target identification and drug repurposing
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) development landscape
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Key Players

Actavalon Inc
Active Biotech AB
Ampio Pharmaceuticals Inc
AnTolRx Inc
Aqilion AB
Artus Therapeutics Inc
Aslan Pharmaceuticals Ltd
Azora Therapeutics Australia Pty Ltd
Bayer AG
Dermavant Sciences Inc
Hercules Pharmaceuticals BV
Ikena Oncology Inc
JAGUAHR Therapeutics Pte Ltd
Magenta Therapeutics Inc
Nogra Pharma Ltd
Pfizer Inc
Phenex Pharmaceuticals AG
Shenogen Pharma Group Ltd
Sol-Gel Technologies Ltd
Welichem Biotech Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Overview

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Therapeutics Development

Products under Development by Stage of Development

Products under Development by Therapy Area

Products under Development by Indication

Products under Development by Companies

Products under Development by Universities/Institutes

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Therapeutics Assessment

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Companies Involved in Therapeutics Development

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Drug Profiles

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Dormant Products

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Discontinued Products

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

List of Tables

Number of Products under Development by Stage of Development, 2022

Number of Products under Development by Therapy Areas, 2022

Number of Products under Development by Indications, 2022

Number of Products under Development by Companies, 2022

Products under Development by Companies, 2022

Number of Products under Investigation by Universities/Institutes, 2022

Products under Investigation by Universities/Institutes, 2022

Number of Products by Stage and Mechanism of Actions, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Dormant Products, 2022

Dormant Products, 2022 (Contd..1)

Discontinued Products, 2022

List of Figures

List of Figures

Number of Products under Development by Stage of Development, 2022

Number of Products under Development by Therapy Areas, 2022

Number of Products under Development by Top 10 Indications, 2022

Number of Products by Mechanism of Actions, 2022

Number of Products by Stage and Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

Frequently Asked Questions

The key therapy areas in the AHR pipeline products market are oncology, immunology, gastrointestinal, dermatology, central nervous system, infectious disease, metabolic disorders, ophthalmology, and respiratory.

The key mechanisms of action in the AHR pipeline products market are Aryl Hydrocarbon Receptor Agonist and Aryl Hydrocarbon Receptor Antagonist.

The key routes of administration in the AHR pipeline products market are oral, intravenous, inhalational, intraarticular, and topical.

The key molecule types in the AHR pipeline products market are small molecule, biologic, synthetic peptide, cell therapy, and monoclonal antibody.

Some of the major companies in the AHR pipeline products market are Actavalon Inc, Active Biotech AB, Ampio Pharmaceuticals Inc, AnTolRx Inc, Aqilion AB, Artus Therapeutics Inc, Aslan Pharmaceuticals Ltd, Azora Therapeutics Australia Pty Ltd, Bayer AG, and Dermavant Sciences Inc.

$3,500

Can be used by individual purchaser only

$10,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Still undecided about purchasing this report?

Enquire Before Buying

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods